CD14 and ovarian cancer: Analysis of peripheral blood neutrophils (CD14−, CD15+) revealed that, compared to healthy donors, patients harbouring ovarian cancers had an increased proportion of neutrophils with intermediate expression of CD10 and CD16; characteristics previously reported as indicative of immature phenotype38,39 (Fig. 7a, b).